IP Library Granted Patent US 9,603,773
Granted Patent B2
US 9,603,773 · App. 14/805,346 · Granted Mar 28, 2017

Methods and systems for treating cardiovascular disease using an implantable electroacupuncture device

Inventors: Jeffrey H. Greiner (Valencia, CA); David K. L. Peterson (Valencia, CA); Chuladatta Thenuwara (Valencia, CA)
Assignee: Valencia Technologies Corporation
A61H39/002A61N1/3606A61N1/36114A61N1/36117A61N1/36125A61N1/36175A61N1/3756A61N1/37205A61N1/37223A61H2201/01A61N1/36153A61N1/36157A61N1/3782A61N1/3787Y10T29/49002
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,603,773
App. No.
14/805,346
Granted
Mar 28, 2017
Kind
B2
Abstract

An exemplary method treating a cardiovascular disease in a patient includes 1) generating, by an electroacupuncture device implanted beneath a skin surface of the patient at an acupoint corresponding to a median nerve of the patient, stimulation sessions at a duty cycle that is less than 0.05, wherein the duty cycle is a ratio of T3 to T4, each stimulation session included in the stimulation sessions has a duration of T3 minutes and occurs at a rate of once every T4 minutes, and the electroacupuncture device comprises a central electrode of a first polarity and an annular electrode of a second polarity and that is spaced apart from the central electrode; and 2) applying, by the electroacupuncture device, the stimulation sessions to the median nerve by way of the central electrode and the annular electrode in accordance with the duty cycle.

Claims (36)

1. A method of treating a cardiovascular disease in a patient, comprising:

generating, by an electroacupuncture device implanted beneath a skin surface of the patient at an acupoint corresponding to a median nerve of the patient, stimulation sessions at a duty cycle that is less than 0.05, wherein

each stimulation session included in the plurality of stimulation sessions comprises a series of stimulation pulses,

the duty cycle is a ratio of T3 to T4,

each stimulation session included in the stimulation sessions has a duration of T3 minutes and occurs at a rate of once every T4 minutes, and

the electroacupuncture device comprises a central electrode of a first polarity centrally located on a first surface of a housing of the electroacupuncture device and an annular electrode of a second polarity and that is spaced apart from the central electrode; and

applying, by the electroacupuncture device, the stimulation sessions to the median nerve by way of the central electrode and the annular electrode in accordance with the duty cycle.

2. The method of claim 1 , wherein the stimulation sessions are configured to reduce sympathetic activity within the patient.

3. The method of claim 1 , wherein the cardiovascular disease comprises at least one of heart failure, coronary artery disease, myocardial ischemia, and angina.

4. The method of claim 1 , wherein the acupoint comprises PC6.

5. The method of claim 1 , wherein T3 is at least 10 minutes and less than 60 minutes, and wherein T4 is at least 1440 minutes.

6. The method of claim 1 , further comprising:

receiving, by the electroacupuncture device from a device external to the electroacupuncture device, a control command that sets the times T3 and T4 to appropriate values configured to treat the cardiovascular disease;

wherein the generating of the stimulation sessions is performed in accordance with the control command.

7. The method of claim 6 , wherein the receiving of the control command comprises detecting, with a magnetic field sensor included in the electroacupuncture device, a magnetic field generated by the device external to the electroacupuncture device.

8. The method of claim 1 , wherein the housing is coin-sized and coin-shaped.

9. The method of claim 1 , wherein the annular electrode is located on the first surface of the housing.

10. The method of claim 1 , wherein the annular electrode comprises a ring electrode located around a circumferential edge of the housing.

11. The method of claim 1 , wherein the applying of the stimulation sessions to the median nerve further comprises applying the stimulation sessions by way an electrode included on a lead connected to the electroacupuncture device.

12. The method of claim 1 , further comprising powering electronic circuits within the electroacupuncture device with a battery having an internal impedance of at least 5 ohms.

13. An electroacupuncture device for treating a cardiovascular disease in a patient, comprising:

a housing configured to be implanted beneath a skin surface of the patient at an acupoint corresponding to a median nerve of the patient;

a central electrode of a first polarity and centrally located on a first surface of the housing;

an annular electrode of a second polarity and that surrounds the central electrode on the first surface of the housing, the annular electrode being spaced apart from the central electrode; and

pulse generation circuitry located within the housing and electrically coupled to the annular and central electrodes and that

generates stimulation sessions configured to target the median nerve at a duty cycle that is less than 0.05, and

applies the stimulation sessions to the median nerve configured to target the median nerve by way of the central electrode and the annular electrode in accordance with the duty cycle,

such that

each stimulation session included in the plurality of stimulation sessions comprises a series of stimulation pulses,

the duty cycle is a ratio of T3 to T4, and

each stimulation session included in the stimulation sessions has a duration of T3 minutes and occurs at a rate of once every T4 minutes.

14. The electroacupuncture device of claim 13 , wherein the stimulation sessions are configured to reduce sympathetic activity within the patient.

15. The electroacupuncture device of claim 13 , wherein the cardiovascular disease comprises at least one of heart failure, coronary artery disease, myocardial ischemia, and angina.

16. The electroacupuncture device of claim 13 , wherein the acupoint comprises PC6.

17. The electroacupuncture device of claim 13 , further comprising a magnetic field sensor that receives, from a device external to the electroacupuncture device, a control command that sets the times T3 and T4 to appropriate values configured to treat the cardiovascular disease.

18. The electroacupuncture device of claim 13 , further comprising a battery that powers the pulse generation circuitry, the battery having an internal impedance of at least 5 ohms.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded May 6, 2026
From: MEDTRONIC, INC.
To: VALENCIA BIOSCIENCE, INC.
Reel/Frame 075721/0223 →
SECURITY INTEREST Recorded Oct 27, 2023
From: VALENCIA BIOSCIENCE, INC.
To: MEDTRONIC, INC.
Reel/Frame 065382/0738 →
SECURITY INTEREST Recorded Aug 4, 2021
From: VALENCIA BIOSCIENCE, INC.
To: MEDTRONIC, INC.
Reel/Frame 057088/0352 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 3, 2020
From: VALENCIA TECHNOLOGIES CORPORATION
To: VALENCIA BIOSCIENCE, INC.
Reel/Frame 053684/0656 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 21, 2015
From: GREINER, JEFFREY H.; PETERSON, DAVID K. L.; THENUWARA, CHULADATTA
To: VALENCIA TECHNOLOGIES CORPORATION
Reel/Frame 036146/0951 →
Continuity (11)
Continuation 14669155 · Mar 26, 2015
Division 13622653 · Sep 19, 2012
Provisional Application 61626339 · Sep 23, 2011
Provisional Application 61606995 · Mar 6, 2012
Provisional Application 61609875 · Mar 12, 2012
Provisional Application 61672257 · Jul 16, 2012
Provisional Application 61672661 · Jul 17, 2012
Provisional Application 61673254 · Jul 19, 2012
Provisional Application 61674691 · Jul 23, 2012
Provisional Application 61676275 · Jul 26, 2012
Related Publication 20150321006A1 · Nov 12, 2015